1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,

Slides:



Advertisements
Similar presentations
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Advertisements

Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.
Types of Cost Sharing Mandatory: When the sponsor stipulates that cost sharing or matching funds are required as a condition of receiving an award. Specifically.
Welcome Vendor Representative Orientation
The Role and Value of Internal Audit Association of Credit Union Internal Auditors September 26, 2012.
Orientation for Academic Program Reviews
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Disclosure of Conflicts of Interest and Commitment Why do we collect COI disclosures, and from whom do we collect? A note about our system of collection,
PROPOSAL TO ESTABLISH THE UNIVERSITY OF HAWAI‘I HOSPITALITY AND TOURISM INSTITUTE Submitted by University of Hawai‘i Hospitality and Tourism Consortium.
Open Meetings Briefing for Public Body Chairpersons Presented by the Office of the University Attorney Fall 2001.
Faculty Group Practice Clinical Strategy FGP Board July 09, 2009 Attachment D.
UNIFORM GUIDANCE OVERVIEW. OMB Circulars Before and After A-21 Cost principles for Educational Institutions A-21 Cost principles for Educational Institutions.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Financial Conflict of Interest
The University of California Sponsored Project Funding: Pre-Award Nancy R. Lewis Director, Sponsored Projects Administration University of California,
Component 2: The Culture of Health Care Unit 3: Health Care Settings— The Places Where Care Is Delivered Lecture 3 This material was developed by Oregon.
VA MOU’s The Good, the Bad and the Ugly Chris G. Green, CPA Director, Sponsored Programs.
Triton Group, LLC.Lebow, Malecki & Tasch, LLC.1 BUILDING A BETTER ORGANIZATION BY COLLABORATING WITH OTHER BUSINESS PARTNERS: RISKS AND BENEFITS Martin.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Governance & Organizational Structure Paula Autry President, Mount Carmel East Mount Carmel Health System.
University of Rochester Board of Trustees Orientation Financial Overview and Issues October 15, 2008.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Governance & Organizational Structure
UNM and Health System Internal Audit Departments Internal Audit Department Orientation Manu Patel, Internal Audit Director Purvi Mody, Executive Director,
Interest and Outside Activity Reporting Form Released July 16, 2012.
S H A C The Operations of Student Health Advisory Committee at UCLA June 3, 2011 Chris Lewis Director of Nursing SHAC Liaison Aria Eshraghi Graduate Student.
Task Force on Federal Grant and Contract Compliance: Implementation Activities Dr. Jack Finney and Dr. Bill Knocke.
The Report of the Provost’s Advisory Group on the SUNY Assessment Initiative September 2009 Tina Good, Ph.D. President Faculty Council of Community Colleges.
Academic Advancement As A Clinician Educator Donald W. Reynolds Foundation Grantee 2010 Annual Meeting Daniel Swagerty, MD, MPH Professor, Departments.
UAMS College of Medicine New Faculty Orientation August 24 th, 2010 Opening SessionClinician SessionResearch Session.
+ Conflict of Interest in Physician-Industry Relationships.
PROMOTION AND TENURE FOR CLINICAL SCIENTISTS – BOTH PATHWAYS Peter Emanuel, M.D. Laura Lamps, M.D.
Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.
Collaborative Fall Reduction Program Jane Swaim, RN CNO, Senior Vice President, Nursing Jeannie Smith RN, Clinical Data Coordinator, Quality Management.
1 University of Pittsburgh Presentation to Department of Family Medicine Outside Engagements within the Industry Relationship Policy February 8, 2010 Barbara.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
University of Pittsburgh Presentation to Schools of Pharmacy and Nursing: Consulting Requirements within the Industry Relationship Policy Presented by.
Promotion Process A how-to for DEOs. How is a promotion review initiated? Required in the final probationary year of a tenure track appointment (year.
Managing Conflicts of Interest at the IRB and Institutional Level: INSTITUTIONAL CONFLICTS OF INTEREST Claudia R. Adkison, J.D., Ph.D. Executive Associate.
Rebecca Nickleson, MS, CRA Assistant Director Office of Research & Sponsored Programs.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
POST-TENURE REVIEW: Report and Recommendations. 2 OVERVIEW Tenure Field Test Findings Recommendations This is a progress report. Implementation, assessment,
Hospital Administration. It is the management of the hospital as a business. The administration is made up of medical and health services managers (sometimes.
Powers, Duties, and Responsibilities of the Policy Commission.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
JANUARY 21, 2014 SERIES 4, SESSION 1 OF AAPLS MECHANISMS OF COLLABORATION: PROPOSALS THAT INCLUDE MORE THAN ONE TUFTS DEPARTMENT OR SCHOOL, OR A COLLABORATION.
COUNCIL FOR COMMUNITY &TECHNICAL COLLEGE EDUCATION POWERS, DUTIES, AND RESPONSIBILITIES.
Promotions on the Clinician Educator Track Larry L. Swift, Ph.D. Vice Chair for Faculty Affairs Department of Pathology, Microbiology & Immunology.
Regional Behavioral Health Boards Chapter 31, Title 39 Idaho Code.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
NATIONAL CONFERENCE Intellectual Property Policies for Universities and Innovation dr. sc. Vlatka Petrović Head, Technology Transfer Office Acting Head,
Lilly Answers that Matter. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical.
.62 STRATEGIC PLANNING Framework, Process, & Calendar June 2008 LOMA LINDA UNIVERSITY ADVENTIST HEALTH SCIENCES CENTER.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
AACN – Manatt Study In February 2015, the AACN Board of Directors commissioned Manatt Health to conduct a study on how to position academic nursing to.
Fundamentals of Health Information – Week 1 Robyn Korn, MBA, RHIA, CPHQ.
Matt Irwin, Research Administrator Tiffany Barnes, Financial Administrator Michelle Melin-Rogovin, MA, Associate Director, Research Admin.
Compensation Plan & Incentive Pay Making Sense of X,Y, and Z New Faculty Orientation UCSF Radiology and Biomedical Imaging Session 1: September 17, 2014.
Fifteenth Board Meeting Geneva, April 2007 Ethics Committee Annual Report Professor Sheila Dinoshe Tlou, M.P., POH (Chair) Dr Brian Brink (Vice Chair)
Michael Scian, MBA, JD Assistant Director of Compliance University of Florida.
eCOI electronic Conflict of Interest
Crouse Health Hospital
Proposal Routing Overview
University of Pittsburgh
Promotion on the Clinician Educator and Clinical Practice Tracks
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin, MD - Chief Medical Officer Timothy Albertson, MD,MHP, PhD - Professor/Division Chief Garen Wintemute, MD,MHP – Professor, Emergency Medicine

2 Our Goals for Sharing Vendor Policy Development Vendor Policy Implementation Bumps in the Road Where we are today Best Practices – Campus Sharing & Q/A

3 JAMA Article, P&T Committee (sub), Pharma Code Systemwide start Medical Staff, P&T - whose decision was it to extend the definition of “vendor” to include all, rather then just health care vendors. Policy Rollout Industry Relations Committee (IRC) development Starting Points

4 UCDHS Vendor Relations Background on Development JAMA Article Pharma Code Dr. Wintemute’s interest/guts to move forward His foresight for soliciting Dr. Albertson for assistance as the Chair of the P&T Committee P&T appoints a sub-committee for recommendations

5 P&T Sub-Committee Important acknowledgement that ownership of the recommendations being made were done through a Medical Staff Committee Vendor relations would apply to “all” vendors, not only health care related Recognizing existing policies that covered COI, financial interest, preceptorships and manufacturer relations Appointment of Dr. Albertson to the newly formed UCOP committee to develop systemwide vendor policy

6 UCOP Vendor Committee Early draft of the UCOP policy was used to initiate the UCDHS Vendor Policy. P&T subcommittee recommendation to the Dean who codified the policy. Presentation to Governing Body UCDHS Vendor Relations Policy approved Recognition that the success of this policy would require transparency and buy-in from the bottom-up.

7 Policy Implementation Rollout  CMO/CCO, Allan Siefkin, MD committed to education  Peer Pressure – Evolutionary change from the bottom  Transparency and light on the subject

8 Rollout CMO/CCO Plan Six months prior to policy implementation the campaign began Periodic Notifications Education Focus Groups - Medical Staff - Department Managers, Department CAO’s, Nursing - Individual Department Faculty/Resident Meetings - Marketing & Fundraising personnel - Early version of FAQ’s developed and distributed

9 Important Notes Transparency Peer pressure – Evolutionary change Concerns about implications for clinical research and the need to maintain industry relationships to further science and funding

10 System Developments/Components P&T Committee Products and Standardization Committee Value Analysis Committee Medical Staff Committee Collaborative committee with the hospital Emphasis on supply purchasing for the OR

11 Concerns about the Vendor Relations Policy from Faculty, Residents and Staff Food - need to budget or obtain unrestricted funds Samples – Most had been removed due to stricter Joint Commission requirements Additional need for samples imposed a need for policy requiring Pharmacy to receive and distribute Recognized Pharma Patient Assistance Programs No distribution to any individual

12 Supporting Mission Care – Research Important reminder for faculty related to: speakers’ bureaus compensation plan consulting/outside professional activities

13 Recognized Need Based on the number of questions to various sources throughout the institution Need to coordinate Need to provide direct source Establish formal committee to address questions about Vendor Policy implementation Ability for physicians to “plug-in”

14 Dean’s Recommendation Industry Relations Committee Charge: o This committee is advisory to the Vice Chancellor of Human Health Sciences and reports to the UCDHS Executive Compliance Committee to draft directives and review health system policy; provide resources and direction to faculty and administration; review annual faculty conflict of interest disclosure statements; review teaching, and professional service arrangements or proposals; and field questions and inquiries related to conflict of commitment, conflict of interest and vendor relations for faculty and staff. o Conduct substantive review of issues presented. o Recommend changes or restrictions in the project and/or recommend changes to manage, reduce or eliminate potential conflicts of interest. o Recommendation whether the grant, contract, or gift should be accepted. o The committee will meet monthly and may conduct business outside of regularly scheduled meetings when the Chair of the Committee deems necessary.

15 Best for Last - Interactive Sharing Open Sharing